I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 7 studies | 33% ± 9% | |
| fibroblast | 6 studies | 22% ± 9% | |
| classical monocyte | 5 studies | 25% ± 7% | |
| pericyte | 5 studies | 19% ± 4% | |
| epithelial cell | 5 studies | 40% ± 11% | |
| CD4-positive, alpha-beta T cell | 4 studies | 20% ± 3% | |
| conventional dendritic cell | 4 studies | 29% ± 13% | |
| endothelial cell | 4 studies | 30% ± 7% | |
| regulatory T cell | 4 studies | 17% ± 2% | |
| hematopoietic precursor cell | 3 studies | 28% ± 9% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 18% ± 1% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 20% ± 4% | |
| non-classical monocyte | 3 studies | 28% ± 4% | |
| myofibroblast cell | 3 studies | 18% ± 2% | |
| smooth muscle cell | 3 studies | 19% ± 2% | |
| abnormal cell | 3 studies | 26% ± 12% | |
| macrophage | 3 studies | 20% ± 3% | |
| CD8-positive, alpha-beta T cell | 3 studies | 18% ± 3% | |
| dendritic cell | 3 studies | 36% ± 13% | |
| intestinal crypt stem cell | 3 studies | 19% ± 3% | |
| plasmacytoid dendritic cell | 3 studies | 21% ± 4% |
